During these Dynamic Talks, 2 top experts will bring crystal ball session (20’) bringing their vision to how to approach relevant discussions that are going on;

• Real case studies of when and how AI has been used to meet the challenges of the new commerce
• AI and ML – understanding what the real impact is of using new technology and how will change your price optimisation process    

During these Dynamic Talks, 4 top experts will bring crystal ball session (20’) bringing their vision to how to approach relevant discussions that are going on:

• Ensure data quality – Hear real examples of the processes implemented with different type of data such as parameters & frequency to be synchronized
• Key challenges and solutions implemented to be able to connect all the data flow and different data sources integrated to a pricing tool    

During these Dynamic Talks, 3 top experts will bring visionary talk sessions (3×20’) bringing answers to relevant discussions that are going on:

• Real world showcases of moving from selling products to selling products+solutions+services and how to price them
• Monetisation of data: the use of tokens as a pricing technique and practical advice of what tools and methods are available    

During these Dynamic Talks, 4 top experts will bring rapid fire sessions (15’) bringing answers to relevant discussions that are going on ;

• How to align your commercial excellence practices and stakeholder engagement in different countries and manage your global price list strategy
• Real examples of how to justify the price difference in different products, services, and countries – how can we present this to our customers and avoid losing them?    

During these Dynamic Talks, 3 top experts will bring crystal ball session (20’) bringing their vision to how to approach relevant discussions that are going on:

• Sales excellence: How to increase sales conversion and margin in times of high pressure to recover revenue
• Discount management: How to increase discount efficiency by assessing price acceptance in real-time    

During these Dynamic Talks, 4 top experts will bring Crystal Ball Sessions (20’) bringing their vision to how to approach relevant discussions that are going on ;</p

• AI-Based Pricing: new models on how AI & ML is being used and how it is implemented to define more dynamic pricing strategy
   
• Analysis of how AI can help us with the analysis of historical data how it will shift your price optimisation process
    

During these Dynamic Talks, 2 top experts will bring visionary talks (20’) bringing their vision to how to approach relevant discussions that are going on ;

• The role of Revenue Growth Management to face new consumer behaviour, distribution and economic trends
   
• How to create and extract consumer value amongst channels
   
• Beyond strategies and analytics, understand the importance of engaging of internal and external stakeholders
    

During these Dynamic Talks, 3 top experts will bring rapid fire session (3×15’) bringing their vision to how to approach relevant discussions that are going on ;

• Analysis of key components of eCommerce pricing in different segments and in different industries  
   
• Hear successful real case studies of how the integration was done and key takeaways of innovative ways of using eCommerce
   
• Capture the best customers in different digital channels to establish a successful eCommerce strategy
    

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

• From greater adoption of Real-World Evidence to Joint EU HTA and increased cross-border collaboration – what’s the impact of new Market Access and Pricing trends in Europe in a post-pandemic economy?
   
• Pricing and Market Access launch excellence: identifying key drivers and challenges for a successful launch in a climate of change
   
• Assessing the side effects of greater Net Price Transparency for innovative medicines in Europe – adverse pricing consequences or perceived price fairness?

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

• How can international collaboration between HTA and regulatory bodies promote knowledge exchange, efficiency of information production thus driving transparency of process of assessment and decision-making?
   
• Exploring a novel approach to RWE generation. How can the pharmaceutical and biotech industry leverage new technologies to get evidence faster and more patient-focused than the standard?
   
• Optimising  External Reference Pricing (ERP) in a challenging global scenario. How can a company strategically approach the challenges of ERP?

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

• Why a strategic approach is key to digital transformation: from the adoption and implementation of advanced technologies to organisational changes, collaboration, and supportive leadership
   
• How is big data and AI technology driving market access strategy and practice? How can AI and machine learning help maximise clinical trial data, identify RWE gaps and generation of evidence to meet HTA requirements?
   
• Assessing how predictive analytics can be deployed to inform pricing strategies, determine appropriate launch sequences, and optimise discounts

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

• Exploring real-life examples of successful tendering in medical devices and pharmaceuticals
   
• EValue-based tendering in Life Sciences: assessing challenges and opportunities for adding quality criteria beyond price-only evaluation of tenders
   
• Leveraging latest technologies to evaluate tender opportunities and find the optimal price for the product

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

• Value-based pricing and contracting for innovative MedTech: assessing main barriers and opportunities
   
• How are payers embracing digital health tools such as connected devices and telemedicine? Exploring reimbursement models for digital health products with country-focused examples
   
• Learning how to successfully achieve payer reimbursement with outcomes-based risk-sharing models.
   
• From Device-Focused to Service-Focused: capturing the value-based procurement opportunity to get ahead in a competitive marketplace

During these Dynamic Talks, 3 top experts will bring crystal ball sessions (3×20’) bringing answers to relevant discussions that are going on ;

• Assessing top barriers for value-based pricing adoption in pharma. What are the challenges facing value-based pricing implementation? How can we achieve a worthy transition to outcomes-based contracts? 
• Exploring alternative pricing and contracting models for next generation therapies. What are the main tendencies for contracting preferences based on the product value? How can the industry successfully manage the challenges in ATMPs pricing settings and reimbursements?    
• Indication-based pricing of innovative medicines – pragmatic or idealistic?    

During these Dynamic Talks, 4 top experts will bring visionary talks (4×15’) bringing answers to relevant discussions that are going on ;

• Discovering how predictive analytics can be deployed to inform pricing strategies, determine appropriate launch sequences and optimise discounts
• Harnessing the value of Big Data: how can the industry create real and identifiable gains to make a meaningful impact? Is building an advanced analytics capability worth the investment?
• Exploring disruptive technologies for improved transparency, market access and collaboration between payers, HTAs, manufacturers and patients    

During these Dynamic Talks, 3 top experts will bring crystal ball sessions (3×20’) bringing answers to relevant discussions that are going on ;

• What impact will COVID-19 have on the future of pricing and market access? Achieving pricing excellence in uncertain times
• Analysing the successful revival of public-private partnerships. Will these collaborations impact positively the life sciences industry and the access and optimal prices of innovative and costly drugs?    
• How can the Healthcare sector leverage the accelerated switch to digital experienced in 2020 in a way that could bring operational and financial benefits long after the pandemic?    

During these Dynamic Talks, 2 top experts will bring Visionary Talks  (20’) bringing their vision to how to approach relevant discussions that are going on:

• Why advanced pricing capabilities are key to serving the omnichannel buyer
• The six stages of Digital Selling Maturity and the key priorities for focus in each stage    
• How your organization can gain competitive advantage through digital acceleration    

During these Dynamic Talks, 3 top experts will bring rapid fire sessions (3×12’) bringing answers to relevant discussions that are going on ;

• The available tools supporting the implementation of pricing excellence and to integrate the marketing, pricing and sales capabilities  
   
• Real examples of how to master Revenue Growth Management with new technology tools
   
• Explore the new tools available to manage big data and algorithms and how to use them?
   
• Real case studies of price optimisation solutions and software
    

During these Dynamic Talks, 2 top experts will bring rapid fire sessions (2×12’) bringing answers to relevant discussions that are going on ;

• Understanding the implications of the pandemic on life sciences pricing strategies
• How will pricing be managed within an overall platform to develop treatments for COVID-19 while achieving affordable access?
• Will payers deal differently with assessing and valuing products ?    

During these Dynamic Talks, 2 top experts will bring visionary talks (2×20’) bringing answers to relevant discussions that are going on ;

• How can we harmonise processes in HTA submissions?
• How can we harmonise processes across the EU?
• How are different HTA agencies operating?